Publications by authors named "Hongrong Xu"

Claim this Profile
M
Multiple-Dose Up-Titration Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Omecamtiv Mecarbil in Healthy Chinese Subjects.
Xuening Li, Hui Li, Hongrong Xu, Fei Yuan, Hanjing Chen

Drugs R D· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mass Spectrometric Screening for Improving Enzymatic Conversion of Formaldehyde into C2 and C3 Products.
Yizhou Luo, Lihao Fu, Jueru Chen, Hongrong Xu, Zeqi Song

ACS Synth Biol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of various tilt angles on radiation dose and image quality in pediatric head computed tomography: A phantom study.
Hongrong Xu, Jiawen Zhao, Zhen Xu, Bo Liu, Jinhua Cai

J Appl Clin Med Phys· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Scoring System Based on Diffusion Tensor Imaging and Blood Biochemistry Tests for Diagnosing Biliary Atresia in Infants.
Bo Liu, Xiaoying Ni, Jin Zhu, Shuang Ding, Helin Zheng, Hongrong Xu

Children (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Safety of Linezolid Tablets of 2 Different Manufacturers in Healthy Chinese Subjects in Fasting and Fed States.
Hanjing Chen, Hongrong Xu, Fei Yuan, Hui Li, Lei Sheng, Xuening Li

Clin Pharmacol Drug Dev· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the bioequivalence and safety of liraglutide injection Victoza in healthy Chinese subjects: a randomized, open, two-cycle, self-crossover phase I clinical trial.
Chao Liu, Hongrong Xu, Fei Yuan, Hanjing Chen, Lei Sheng, Hongmei Xu, Xuening Li

Front Pharmacol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Safety of Eptinezumab in Healthy Chinese Participants: A Randomized Clinical Trial.
Xue-Ning Li, Hong-Rong Xu, Ellen Cui, Kamilla Buchberg Petersen, Janka Ryding

Clin Drug Investig· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defined, low threshold for caesarean section and multidisciplinary team management improves fetal outcome from acute pancreatitis in pregnancy.
Wenhua He, Zhi Zhang, Wenhao Cai, Lingyu Luo, Hongrong Xu

Pancreatology· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SW-BIC-213, as a heterologous booster in healthy adults: an open-labeled, two-centered and multi-arm randomised, phase 1 trial.
Yu-Zhou Gui, Xue-Ning Li, Jing-Xin Li, Ming-Yun Shen, Mei-Wei Zhang, Hong-Rong Xu

EBioMedicine· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Food on the Pharmacokinetics and Safety of a Novel c-Met Inhibitor SCC244: A Randomized Phase I Study in Healthy Subjects.
Juan Wu, Hongrong Xu, Hui Li, Lei Ma, Juan Chen, Xuening Li

Drug Des Devel Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic Interaction of Chiglitazar with CYP3A4 Inducer or Inhibitor: An Open-Label, Sequential Crossover, Self-Control, 3-Period Study in Healthy Chinese Volunteers.
Fei Yuan, Jing Li, Xuening Li, Hui Li, Weili Chen, Hongrong Xu

Clin Pharmacol Drug Dev· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Icosapent Ethyl: An Open-Label, Multiple Oral Dose, Parallel Design Study in Healthy Chinese Subjects.
Fei Yuan, Hui Li, Mengjie Yang, Weili Chen, Hanjing Chen, Hongrong Xu, Xuening Li

Clin Pharmacol Drug Dev· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of dominant conformational epitopes from the whole structure of the proprotein convertase subtilisin/kexin type 9.
Chao Liu, Hongrong Xu, Fei Yuan, Weili Chen, Hanjing Chen, Xuening Li

Biochem Biophys Res Commun· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative MRI Evaluation of Hand Vessels in Children With Congenital Syndactyly Malformation by a Contrast-Enhanced Three-Dimensional Water-Selective Cartilage Scan.
Bo Liu, Jinhua Cai, Xiaofei Tian, Kaiping Huang, Daisong Liu, Hongrong Xu

Front Pediatr· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Sugammadex: An Open-Label, 3-Period, Fixed-Sequence, 3-Single-Doses Study in Healthy Chinese Subjects.
Fei Yuan, Mengjie Yang, Weili Chen, Hanjing Chen, Hongrong Xu, Xuening Li

Clin Pharmacol Drug Dev· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioequivalence Evaluation Between Acarbose and Metformin Fixed-Dose Combination and Corresponding Individual Components in Healthy Chinese Male and Female Subjects.
Chao Liu, Adriaan Cleton, Yubin Sui, Yuwang Liu, Jinyi Li, Hongrong Xu, Xuening Li

Clin Pharmacol Drug Dev· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Projections on Radiation Dose for and Image Quality of Chest Digital Radiography for Children.
Hongrong Xu, Bo Liu, Jinhua Cai, Huan Zheng, Helin Zheng

Curr Med Imaging· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of the use of various imaging units and projections on the radiation dose received by children during chest digital radiography.
Hongrong Xu, Kaiping Huang, Bo Liu, Jinhua Cai, Huan Zheng

PLoS One· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Benfotiamine in Healthy Subjects.
Lei Sheng, Wei Cao, Pingping Lin, Weili Chen, Hongrong Xu, Xuening Li

Drug Des Devel Ther· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetic metrics of F-FDG in normal human organs identified by systematic dynamic total-body positron emission tomography.
Guobing Liu, Hongrong Xu, Pengcheng Hu, Hui Tan, Yiqiu Zhang, Xuening Li

Eur J Nucl Med Mol Imaging· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, Safety and Tolerability of Anacetrapib, a Novel Cholesteryl Ester Transfer Protein (CETP) Inhibitor, After Single and Multiple Doses in Healthy Chinese Subjects.
Hanjing Chen, Weili Chen, Hui Li, Hongrong Xu, Fei Yuan, Xuening Li

Adv Ther· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of SNA001, a Novel Recombinant Human Thyroid Stimulating Hormone Injection, in Patients With Differentiated Thyroid Carcinoma.
Yushen Gu, Hongrong Xu, Yanling Yang, Yan Xiu, Pengcheng Hu, Tao Xu, Xuening Li

Front Endocrinol (Lausanne)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Pharmacokinetics of Aprepitant in Healthy Chinese and Caucasian Subjects.
Meng-Jie Yang, Hong-Rong Xu, Hui Li, Wei-Li Chen, Fei Yuan, Xue-Ning Li

Drug Des Devel Ther· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet inhibitory activity, tolerability, and safety of vicagrel, a novel thienopyridine P2Y12 inhibitor.
Hui Li, Hanjing Chen, Weili Chen, Hongrong Xu, Fei Yuan, Xuefang Liu, Xuening Li

Medicine (Baltimore)· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Safety, Tolerability, And Pharmacokinetic/Pharmacodynamic Study Of Evolocumab In Healthy Chinese Subjects.
Chao Liu, Hong Lu, Fei Yuan, Wei-Li Chen, Hong-Rong Xu, Xue-Ning Li

Clin Pharmacol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis